MessageCompany OverviewCorporate PhilosophyHistoryNews ReleaseMap



Press Release


2008.6.11ReqMed, bene pharmaChem GmbH & Co., KG and Asahi Kasei Pharma Corporation announce the exclusive license agreement on Sodium Pentosan Polysulfate.




News Release


MediaTitle
2007.02.12R&D FOCUS drugnews
volume 16 No.7
p.19,20,24
Updates from ReqMed
· ADHD therapy, ReqMed/Psychogenics
· injectable pentosan polysulfate sodium,ReMed4
2006.05.08BioWorld TodayHow Frustrated Firm ReqMed Created New Biotech Strategy
Bridgingng Drug Development Gap Z
2006.01.30PHARMA JAPAN
1997 p.17
JPLA Seminar
Bioventures, Pharma Companies Working Together More Closely
2002.12.24PNAS
Vol. 99, Issue 26
17107-17112
Protection against ischemic brain injury by protein therapeutics
2000.12.15International Herald Tribune
No.695
Japanese Try to Bridge The Biotechnology Gap
Government Earmarks Funds for Start-up




Copyright (C) 2008 ReqMed Company, Ltd. All Rights Reserved.